J Transl Med. 2013 Mar 13;11(1):64.
Antitumor effects of L-BLP25 Antigen-Specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model.
Wurz GT, Gutierrez AM, Greenberg BE, Vang DP, Griffey SM, Kao CJ, Wolf M, Degregorio MW.88
Mechanism of action is a CD8 T cell also known as a class I restricted killer cell. Oh and it works.